Left ventricular dilatation and subclinical renal damage in primary hypertension

Journal of Hypertension

Volumn 33, Issue 3, 2015, Pages 605-611

  Ratto, Elena ^a   Viazzi, Francesca ^a   Bonino, Barbara ^a   Gonnella, Annalisa ^a   Garneri, Debora ^a   Parodi, Emanuele L ^a   Bezante, Gian Paolo ^a   Derchi, Lorenzo E ^a   Leoncini, Giovanna ^a   Pontremoli, Roberto ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

albuminuria; echocardiography; hypertension; left ventricular hypertrophy; nephrosclerosis

Indexed keywords

ADULT; ARTICLE; CONCENTRIC DILATED HYPERTROPHY; CONCENTRIC NONDILATED HYPERTROPHY; DILATATION; DOPPLER ECHOGRAPHY; ECCENTRIC DILATED HYPERTROPHY; ECCENTRIC NONDILATED HYPERTROPHY; ECHOCARDIOGRAPHY; ECHOGRAPHY; FEMALE; GEOMETRY; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; KIDNEY INJURY; LEFT VENTRICULAR DILATATION; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; PRIORITY JOURNAL; PROGNOSIS; RENAL SYSTEM PARAMETERS; RENAL VOLUME; RESISTIVE INDEX; SUBCLINICAL RENAL DAMAGE; URINARY EXCRETION; ALBUMINURIA; COMPLICATION; HEMODYNAMICS; KIDNEY; MIDDLE AGED; PATHOPHYSIOLOGY;

ADULT; ALBUMINURIA; ECHOCARDIOGRAPHY; FEMALE; HEMODYNAMICS; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; KIDNEY; MALE; MIDDLE AGED; PROGNOSIS;

EID: 84922432953     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0000000000000430     Document Type: Article

References (31)

1. Devereux RB, De Simone G, Ganau A, Roman MJ. Left ventricular hypertrophy and geometric remodeling in hypertension: stimuli, functional consequences and prognostic implications. J Hypertens 1994; Suppl 12:S117-S127
2. Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Gattobigio R, Zampi I, et al. Prognostic value of left ventricular mass and geometry in systemic hypertension with left ventricular hypertrophy. Am J Cardiol 1996; 78:197-202
3. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 1991; 114:345-352
4. Krumholz HM, Larson M, Levy D. Prognosis of left ventricular geometric patterns in the Framingham Heart Study. J Am Coll Cardiol 1995; 25:879-884
5. Khouri MG, Peshock RM, Ayers CR, De Lemos JA, Drazner MH. A 4-tiered classification of left ventricular hypertrophy based on left ventricular geometry: the Dallas heart study. Circ Cardiovasc Imaging 2010; 3:164-171
6. Bang CN, Gerdts E, Aurigemma GP, Boman K, Dahlöf B, Roman MJ, et al. Systolic left ventricular function according to left ventricular concentricity and dilatation in hypertensive patients: the Losartan Intervention For Endpoint reduction in hypertension study. J Hypertens 2013; 31:2060-2068
7. Bang CN, Gerdts E, Aurigemma GP, Boman K, De Simone G, Dahlöf B, et al. Four group classification of left ventricular hypertrophy based on ventricular concentricity and dilatation identifies a low-risk subset of eccentric hypertrophy in hypertensive patients. Circ Cardiovasc Imaging 2014; 7:422-429
8. Ruilope LM. The kidney as a sensor of cardiovascular risk in essential hypertension. J Am Soc Nephrol 2002; 13 (Suppl 3):S165-S168
9. Culleton BF, Larson MG, Wilson PW, Evans JC, Parfrey PS, Levy D. Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency. Kidney Int 1999; 56:2214-2219
10. Wachtell K, Ibsen H, Olsen MH, Borch-Johnsen K, Lindholm LH, Mogensen CE, et al. Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study. Ann Intern Med 2003; 139:901-906
11. Pontremoli R, Viazzi F, Martinoli C, Ravera M, Nicolella C, Berruti V, et al. Increased renal resistive index in patients with essential hypertension: A marker of target organ damage. Nephrol Dial Transplant 1999; 14:360-365
12. Derchi LE, Leoncini G, Parodi D, Viazzi F, Martinoli C, Ratto E, et al. Mild renal dysfunction and renal vascular resistance in primary hypertension. Am J Hypertens 2005; 18:966-971
13. Doi Y, Iwashima Y, Yoshihara F, Kamide K, Takata H, Fujii T, et al. Association of renal resistive index with target organ damage in essential hypertension. Am J Hypertens 2012; 25:1292-1298
14. Doi Y, Iwashima Y, Yoshihara F, Kamide K, Hayashi S, Kubota Y, et al. Renal resistive index and cardiovascular and renal outcomes in essential hypertension. Hypertension 2012; 60:770-777
15. Viazzi F, Leoncini G, Derchi LE, Pontremoli R. Ultrasound Doppler renal resistive index: a useful tool for the management of the hypertensive patient. J Hypertens 2014; 32:149-153
16. Ikee R, Kobayashi S, Hemmi N, Imakiire T, Kikuchi Y, Moriya H, et al. Correlation between the resistive index by Doppler ultrasound and kidney function and histology. Am J Kidney Dis 2005; 46:603-609
17. Pontremoli R, Sofia A, Ravera M, Nicolella C, Viazzi F, Tirotta A, et al. Prevalence and clinical correlates of microalbuminuria in essential hypertension: the MAGIC Study. Microalbuminuria: a Genoa investigation on complications. Hypertension 1997; 30:1135-1143
18. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18:499-502
19. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, et al. CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150:604-612
20. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989; 2:358-367
21. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N. Echocardiographic assessment of left ventricular hypertrophy:comparison to necropsy findings. Am J Cardiol 1986; 57:450-458
22. Teichholz LE, Kreulen T, Herman MV, Gorlin R. Problems in echocardiographic volume determinations: echocardiographic-angiographic correlations in the presence of absence of asynergy. Am J Cardiol 1976; 37:7-11
23. Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Böhm M, et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2013; 31:1281-1357
24. Leoncini G, Ratto E, Viazzi F, Conti N, Falqui V, Parodi A, et al. Global risk stratification in primary hypertension: the role of the kidney. J Hypertens 2008; 26:427-432
25. Cuspidi C, Muiesan ML, De Luca N, Salvetti M, Agabiti-Rosei E, Schillaci G. Echocardiography in hypertension: a call for standardization from the Working Group on Heart and Hypertension of the Italian Society of Hypertension. High Blood Press Cardiovasc Prev 2014; 21:53-56
26. Ruilope LM, Salvetti A, Jamerson K, Hansson L, Warnold I, Wedel H, Zanchetti A. Renal function and intensive lowering of blood pressure in hypertensive participants of the hypertension optimal treatment (HOT) study. J Am Soc Nephrol 2001; 12:218-225
27. Jensen JS, Feldt-Rasmussen B, Strandgaard S, Schroll M, Borch-Johnsen K. Arterial hypertension, microalbuminuria, and risk of ischemic heart disease. Hypertension 2000; 35:898-903
28. Gansevoort RT, Correa-Rotter R, Hemmelgarn BR, Jafar TH, Heerspink HJ, Mann JF, et al. Chronic kidney disease and cardiovascular risk:epidemiology, mechanisms, and prevention. Lancet 2013; 27:339-352
29. Viazzi F, Leoncini G, Conti N, Tomolillo C, Giachero G, Vercelli M, et al. Microalbuminuria is a predictor of chronic renal insufficiency in patients without diabetes and with hypertension: the MAGIC study. Clin J Am Soc Nephrol 2010; 5:1099-1106
30. Viazzi F, Leoncini G, Ratto E, Falqui V, Parodi A, Conti N, et al. Mild hyperuricemia and subclinical renal damage in untreated primary hypertension. Am J Hypertens 2007; 20:1276-1282
31. Cai QZ, Lu XZ, Lu Y, Wang AY. Longitudinal changes of cardiac structure and function in CKD (CASCADE Study). J Am Soc Nephrol 2014; 25:1599-1608